Obstructive Sleep Apnea

A drug administered through a nasal spray may be an alternative treatment option for patients with obstructive sleep apnea by improving upper airway collapsibility, according to a study published in CHEST.

The FDA has granted 510(k) clearance to a daytime-nighttime appliance, or DNA, to treat patients with mild to moderate obstructive sleep apnea, according to a manufacturer-issued press release.

NASHVILLE, Tenn. — Many survivors of long-term COVID experience difficulties sleeping, but it is unclear whether these disturbances are helping or hurting their recovery, according to a speaker at the CHEST Annual Meeting.

There is still not enough evidence to make a recommendation for or against obstructive sleep apnea screening in asymptomatic adults, according to a statement from the U.S. Preventive Services Task Force.

NASHVILLE, Tenn. — Patients with obstructive sleep apnea and lower household income had higher odds of acute myocardial infarction, all-cause mortality and cardiac arrest, according to data presented at the CHEST Annual Meeting.

Increasing daily step counts may reduce the risk for chronic diseases such as obesity, sleep apnea and major depressive disorder, a study published in Nature Medicine found.

New data have linked more consistent use of CPAP treatment to lower risk for rehospitalization in older adults with obstructive sleep apnea and cardiovascular disease.

Multimodal telemonitoring may aid in weight loss efforts by patients with obstructive sleep apnea and obesity, according to a study published in Chest.

Individuals with moderate/severe obstructive sleep apnea more commonly had floppy eyelid syndrome, shorter tear breakup time and higher ocular redness scores than those with normal/mild OSA, according to a study.

Intranasal corticosteroids for the treatment of mild to severe obstructive sleep apnea in children did not result in significant changes in symptoms, polysomnography findings and neurobehavior, researchers reported in Chest.